Finance

Lists
1760:TPE
Panion & BF Biotech Inc
NT$54,60
0,00%
(0,00) 1D
2 Okt., 13:30:22 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1760...
Open
NT$54,10
High
NT$54,60
Low
NT$54,00
Mkt. cap
4,68 mjd
Avg. vol.
107,81 k
Volume
58,81 k
Dividend
3,66%
Quarterly dividend
NT$0,50
Ex-dividend date
11 Jun. 2026
P/E ratio
21,83
52-wk high
NT$76,40
52-wk low
NT$53,40
EPS
NT$2,50
Shares outstanding
76,74 m
No. of employees
321
Open
NT$54,10
High
NT$54,60
Low
NT$54,00
Mkt. cap
4,68 mjd
Avg. vol.
107,81 k
Volume
58,81 k
Dividend
3,66%
Quarterly dividend
NT$0,50
Ex-dividend date
11 Jun. 2026
P/E ratio
21,83
52-wk high
NT$76,40
52-wk low
NT$53,40
EPS
NT$2,50
Shares outstanding
76,74 m
No. of employees
321
News stories
From web sources and news partners
About Panion & BF Biotech Inc
CEO-
Employees321
Founded1976
Headquarters-
SectorPharmaceutical industry
Websitepbf.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
531,95 m
546,14 m
519,29 m
511,84 m
Cost of goods sold
231,66 m
260,24 m
249,91 m
252,76 m
Cost of revenue
231,66 m
260,24 m
249,91 m
252,76 m
Research and development expenses
45,90 m
44,00 m
41,03 m
36,98 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
154,88 m
168,49 m
144,53 m
160,16 m
Operating expense
200,76 m
213,55 m
186,16 m
197,21 m
Total operating expenses
432,42 m
473,79 m
436,07 m
449,97 m
Operating income
99,52 m
72,35 m
83,22 m
61,86 m
Other non operating income
868,00 k
2,88 m
302,00 k
5,49 m
EBT including unusual items
104,58 m
73,58 m
80,60 m
60,79 m
EBT excluding unusual items
104,58 m
73,49 m
80,67 m
63,33 m
Income tax expense
29,23 m
24,96 m
28,86 m
21,68 m
Effective tax rate
27,95%
33,93%
35,80%
35,67%
Other operating expenses
-
-
-
-
Net income
75,35 m
48,62 m
51,74 m
39,11 m
Net profit margin
14,17%
8,90%
9,96%
7,64%
Earnings per share
-
-
-
-
Interest and investment income
349,00 k
1,32 m
146,00 k
1,48 m
Interest expense
-3,60 m
-3,47 m
-3,45 m
-3,50 m
Net interest expenses
-3,25 m
-2,15 m
-3,31 m
-2,01 m
Depreciation and amortization charges
-
-
-
-
EBITDA
127,81 m
100,99 m
112,84 m
89,17 m
Gain or loss from assets sale
-
125,00 k
-
-
AI content may include mistakes. Learn more
Google-programme